1
|
Mareczek L, Riehl C, Harms M, Reichl S. Analysis of the impact of material properties on tabletability by principal component analysis and partial least squares regression. Eur J Pharm Sci 2024; 200:106836. [PMID: 38901784 DOI: 10.1016/j.ejps.2024.106836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2024] [Revised: 05/27/2024] [Accepted: 06/17/2024] [Indexed: 06/22/2024]
Abstract
Principal component analysis (PCA) and partial least squares regression (PLS) were combined in this study to identify key material descriptors determining tabletability in direct compression and roller compaction. An extensive material library including 119 material descriptors and tablet tensile strengths of 44 powders and roller compacted materials with varying drug loads was generated to systematically elucidate the impact of different material descriptors, raw API and filler properties as well as process route on tabletability. A PCA model was created which highlighted correlations between different powder descriptors and respective characterization methods and, thus, can enable reduction of analyses to save resources to a certain extent. Subsequently, PLS models were established to identify key material attributes for tabletability such as density and particle size but also surface energy, work of cohesion and wall friction, which were for the first time demonstrated by PLS as highly relevant for tabletability in roller compaction and direct compression. Further, PLS based on extensive material characterization enabled the prediction of tabletability of materials unknown to the model. Thus, this study highlighted how PCA and PLS are useful tools to elucidate the correlations between powder and tabletability, which will enable more robust prediction of manufacturability in formulation development.
Collapse
Affiliation(s)
- Lena Mareczek
- Institute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Braunschweig 38106, Germany; Department of Orals Development, Merck Healthcare KGaA, Darmstadt 64293, Germany
| | - Carolin Riehl
- Department of Orals Development, Merck Healthcare KGaA, Darmstadt 64293, Germany.
| | - Meike Harms
- Department of Orals Development, Merck Healthcare KGaA, Darmstadt 64293, Germany
| | - Stephan Reichl
- Institute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Braunschweig 38106, Germany.
| |
Collapse
|
2
|
Kitazoe T, Usui C, Kodaira E, Maruyama T, Kawano N, Fuchino H, Yamamoto K, Kitano Y, Kawahara N, Yoshimatsu K, Shirahata T, Kobayashi Y. Improved quantitative analysis of tenuifolin using hydrolytic continuous-flow system to build prediction models for its content based on near-infrared spectroscopy. J Nat Med 2024; 78:296-311. [PMID: 38172356 DOI: 10.1007/s11418-023-01764-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Accepted: 11/14/2023] [Indexed: 01/05/2024]
Abstract
This study used two types of analyses and statistical calculations on powdered samples of Polygala root (PR) and Senega root (SR): (1) determination of saponin content by an independently developed quantitative analysis of tenuifolin content using a flow reactor, and (2) near-infrared spectroscopy (NIR) using crude drug powders as direct samples for metabolic profiling. Furthermore, a prediction model for tenuifolin content was developed and validated using multivariate analysis based on the results of (1) and (2). The goal of this study was to develop a rapid analytical method utilizing the saponin content and explore the possibility of quality control through a wide-area survey of crude drugs using NIR spectroscopy. Consequently, various parameters and appropriate wavelengths were examined in the regression analysis, and a model with a reasonable contribution rate and prediction accuracy was successfully developed. In this case, the wavenumber contributing to the model was consistent with that of tenuifolin, confirming that this model was based on saponin content. In this series of analyses, we have succeeded in developing a model that can quickly estimate saponin content without post-processing and have demonstrated a brief way to perform quality control of crude drugs in the clinical field and on the market.
Collapse
Affiliation(s)
- Tatsuki Kitazoe
- School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan
| | - Chisato Usui
- School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan
| | - Eiichi Kodaira
- School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan
| | - Takuro Maruyama
- Division of Pharmacognosy, Phytochemistry and Narcotics, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan
| | - Noriaki Kawano
- National Institutes of Biomedical Innovation, Health and Nutrition, 1-2 Hachimandai, Tsukuba, Ibaraki, 305-0843, Japan
| | - Hiroyuki Fuchino
- National Institutes of Biomedical Innovation, Health and Nutrition, 1-2 Hachimandai, Tsukuba, Ibaraki, 305-0843, Japan
| | - Kazuhiko Yamamoto
- National Institutes of Biomedical Innovation, Health and Nutrition, 1-2 Hachimandai, Tsukuba, Ibaraki, 305-0843, Japan
| | - Yasushi Kitano
- Nippon Funmatsu Yakuhin Co., Ltd, 2-5-11, Doshomachi, Chuo-ku, Osaka, 541-0045, Japan
| | - Nobuo Kawahara
- National Institutes of Biomedical Innovation, Health and Nutrition, 1-2 Hachimandai, Tsukuba, Ibaraki, 305-0843, Japan
- The Kochi Prefectural Makino Botanical Garden, Godaisan, Kochi, 781-8125, Japan
| | - Kayo Yoshimatsu
- National Institutes of Biomedical Innovation, Health and Nutrition, 1-2 Hachimandai, Tsukuba, Ibaraki, 305-0843, Japan
| | - Tatsuya Shirahata
- School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan
| | - Yoshinori Kobayashi
- School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.
| |
Collapse
|
3
|
Su J, Zhang K, Qi F, Cao J, Miao Y, Zhang Z, Qiao Y, Xu B. A tabletability change classification system in supporting the tablet formulation design via the roll compaction and dry granulation process. Int J Pharm X 2023; 6:100204. [PMID: 37560487 PMCID: PMC10407897 DOI: 10.1016/j.ijpx.2023.100204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Revised: 07/26/2023] [Accepted: 07/27/2023] [Indexed: 08/11/2023] Open
Abstract
In this paper, the material library approach was used to uncover the pattern of tabletability change and related risk for tablet formulation design under the roll compaction and dry granulation (RCDG) process. 31 materials were fully characterized using 18 physical parameters and 9 compression behavior classification system (CBCS) parameters. Then, each material was dry granulated and sieved into small granules (125-250 μm) and large granules (630-850 μm), respectively. The compression behavior of granules was characterized by the CBCS descriptors, and were compared with that of ungranulated powders. The relative change of tabletability (CoTr) index was used to establish the tabletability change classification system (TCCS), and all materials were classified into three types, i.e. loss of tabletability (LoT, Type I), unchanged tabletability (Type II) and increase of tabletability (Type III). Results showed that approximately 65% of materials presented LoT, and as the granules size increased, 84% of the materials exhibited LoT. A risk decision tree was innovatively proposed by joint application of the CBCS tabletability categories and the TCCS tabletability change types. It was found that the LoT posed little risk to the tensile strength of the final tablet, when Category 1 or 2A materials, or Category 2B materials with Type II or Type III change of tabletability were used. Formulation risk happened to Category 2C or 3 materials, or Category 2B materials with Type I change of tabletability, particularly when high proportions of these materials were involved in tablet formulation. In addition, the risk assessment results were verified in the material property design space developed from a latent variable model in prediction of tablet tensile strength. Overall, results suggested that a combinational use of CBCS and TCCS could aid the decision making in selecting materials for tablet formulation design via RCDG.
Collapse
Affiliation(s)
- Junhui Su
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, PR China
| | - Kunfeng Zhang
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
| | - Feiyu Qi
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
| | - Junjie Cao
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
| | - Yuhua Miao
- The International Department, No. 8 Middle School of Beijing, Beijing 100045, PR China
| | - Zhiqiang Zhang
- Beijing Tcmages Pharmceutical Co. LTD, Beijing 101301, PR China
| | - Yanjiang Qiao
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, PR China
| | - Bing Xu
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, PR China
| |
Collapse
|
4
|
Lyytikäinen J, Kyllönen S, Ervasti T, Komulainen E, Pekarek T, Slunečková J, Leskinen J, Ketolainen J, Kubelka T, Stasiak P, Korhonen O. Challenges encountered in the transfer of atorvastatin tablet manufacturing - commercial batch-based production as a basis for small-scale continuous tablet manufacturing tests. Int J Pharm 2023; 647:123509. [PMID: 37832703 DOI: 10.1016/j.ijpharm.2023.123509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2023] [Revised: 10/07/2023] [Accepted: 10/10/2023] [Indexed: 10/15/2023]
Abstract
As is the case with batch-based tableting processes, continuous tablet manufacturing can be conducted by direct compression or with a granulation step such as dry or wet granulation included in the production procedure. In this work, continuous manufacturing tests were performed with a commercial tablet formulation, while maintaining its original material composition. Challenges were encountered with the feeding performance of the API during initial tests which required designing different powder pre-blend compositions. After the pre-blend optimization phase, granules were prepared with a roller compactor. Tableting was conducted with the granules and an additional brief continuous direct compression run was completed with some ungranulated mixture. The tablets were assessed with off-line tests, applying the quality requirements demanded for the batch-manufactured product. Chemical maps were obtained by Raman mapping and elemental maps by scanning electron microscopy with energy-dispersive X-ray spectroscopy. Large variations in both tablet weights and breaking forces were observed in all tested samples, resulting in significant quality complications. It was suspected that the API tended to adhere to the process equipment, accounting for the low API content in the powder mixture and tablets. These results suggest that this API or the tablet composition was unsuitable for manufacturing in a continuous line; further testing could be continued with different materials and changes in the process.
Collapse
Affiliation(s)
- Jenna Lyytikäinen
- School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland.
| | - Saini Kyllönen
- School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland.
| | - Tuomas Ervasti
- School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland.
| | - Eelis Komulainen
- School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland.
| | | | | | - Jari Leskinen
- Department of Technical Physics, University of Eastern Finland, Kuopio, Finland.
| | - Jarkko Ketolainen
- School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland.
| | | | | | - Ossi Korhonen
- School of Pharmacy, PromisLab, University of Eastern Finland, Kuopio, Finland.
| |
Collapse
|
5
|
Deciphering the role of granule deformation and fragmentation for the tableting performance of some dry granulated powders. POWDER TECHNOL 2022. [DOI: 10.1016/j.powtec.2022.117794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
6
|
Zhao H, Yu Y, Ni N, Zhao L, Lin X, Wang Y, Du R, Shen L. A new parameter for characterization of tablet friability based on a systematical study of five excipients. Int J Pharm 2022; 611:121339. [PMID: 34864121 DOI: 10.1016/j.ijpharm.2021.121339] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 11/22/2021] [Accepted: 11/27/2021] [Indexed: 12/23/2022]
Abstract
In this paper, a new parameter highly relevant to tablet friability is proposed based on a systematical study of the tablet quality attributes and texture performances of five different direct compression excipients, including microcrystalline cellulose, starch, lactose, mannitol, and dicalcium phosphate anhydrous. The new parameter, named Strain/Stress Max, could indicate the tablet's ability against external force to maintain integrity. It was directly obtained from the diametrical breaking test which is extensively used to assess tablet mechanical strength, and thus no extra work is required. The values varied significantly among the tablets formed by materials with different mechanical properties under the same compression pressure. A design space was developed to achieve <1% tablet friability at various combinations of Strain/Stress Max and tensile strength. Additionally, data from binary mixture tablets validated the availability of the constructed design space. And the upper limit of Strain/Stress Max value was advisable for 1.5 MPa-1 for pharmaceutical tablets. In conclusion, the new parameter and design space are available for fast identification of the tablets with acceptable friability to facilitate the development of tablet formulation using as few active pharmaceutic ingredients as possible.
Collapse
Affiliation(s)
- Haiyue Zhao
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, No.1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China
| | - Yating Yu
- Engineering Research Center of Modern Preparation Technology of Traditional Chinese Medicine of Ministry of Education, Shanghai University of Traditional Chinese Medicine, No.1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China; Department of Pharmacy, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, PR China
| | - Ni Ni
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, No.1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China
| | - Lijie Zhao
- Engineering Research Center of Modern Preparation Technology of Traditional Chinese Medicine of Ministry of Education, Shanghai University of Traditional Chinese Medicine, No.1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China.
| | - Xiao Lin
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, No.1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China
| | - Youjie Wang
- Engineering Research Center of Modern Preparation Technology of Traditional Chinese Medicine of Ministry of Education, Shanghai University of Traditional Chinese Medicine, No.1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China
| | - Ruofei Du
- Engineering Research Center of Modern Preparation Technology of Traditional Chinese Medicine of Ministry of Education, Shanghai University of Traditional Chinese Medicine, No.1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China
| | - Lan Shen
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, No.1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China.
| |
Collapse
|
7
|
Jang EH, Park YS, Choi DH. Investigation of the effects of materials and dry granulation process on the mirabegron tablet by integrated QbD approach with multivariate analysis. POWDER TECHNOL 2021. [DOI: 10.1016/j.powtec.2020.12.044] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
8
|
Wikström H, Remmelgas J, Solin S, Marucci M, Sandler N, Boissier C, Tajarobi P. Powder flow from an intermediate bulk container - Discharge predictions and experimental evaluation. Int J Pharm 2021; 597:120309. [PMID: 33540037 DOI: 10.1016/j.ijpharm.2021.120309] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2020] [Revised: 01/08/2021] [Accepted: 01/20/2021] [Indexed: 11/16/2022]
Abstract
Powders are usually dispensed, blended, and transferred between different manufacturing steps in so-called Intermediate Bulk Containers (IBCs), and discharge from an IBC plays a critical role in the ability to manufacture high-quality tablets. To better understand IBC discharge, the flow behavior of selected excipients was comprehensively characterized using a number of techniques including the Hausner ratio/Carr's index, Erweka flow test, FlowPro flow test, shear test and wall friction test as well as FT4 powder rheometer experiments. Jenike's hopper design methodology was then used to predict the minimum non-arching outlet diameter and the mode of flow. Furthermore, the discharge rate from an IBC was predicted using a simple model that takes into account gravity and aerodynamic drag. The predictions were experimentally verified by measuring the discharge rate from a 20 L IBC using five commonly-used excipients. The small-scale Erweka flow test provided the best prediction of the full-scale IBC discharge experiment. Furthermore, a simple model that relied only on the particle size of the material and the diameter of the discharge opening was found to predict the IBC discharge rate remarkably well.
Collapse
Affiliation(s)
- Håkan Wikström
- Oral Product Development, Pharmaceutical Technology & Development, Operations & IT, AstraZeneca Gothenburg, Sweden
| | - Johan Remmelgas
- Oral Product Development, Pharmaceutical Technology & Development, Operations & IT, AstraZeneca Gothenburg, Sweden
| | - Sara Solin
- Pharmaceutical Sciences Laboratory, Faculty of Science and Technology, Åbo Akademi University, Turku, Finland
| | - Mariagrazia Marucci
- Oral Product Development, Pharmaceutical Technology & Development, Operations & IT, AstraZeneca Gothenburg, Sweden
| | - Niklas Sandler
- Pharmaceutical Sciences Laboratory, Faculty of Science and Technology, Åbo Akademi University, Turku, Finland
| | - Catherine Boissier
- Oral Product Development, Pharmaceutical Technology & Development, Operations & IT, AstraZeneca Gothenburg, Sweden
| | - Pirjo Tajarobi
- Early Product Development and Manufacturing, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca Gothenburg, Sweden.
| |
Collapse
|
9
|
Comparison between twin-screw and high-shear granulation - The effect of filler and active pharmaceutical ingredient on the granule and tablet properties. POWDER TECHNOL 2020. [DOI: 10.1016/j.powtec.2020.08.030] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
10
|
Grangeia HB, Silva C, Simões SP, Reis MS. Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives. Eur J Pharm Biopharm 2020; 147:19-37. [DOI: 10.1016/j.ejpb.2019.12.007] [Citation(s) in RCA: 55] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Revised: 12/03/2019] [Accepted: 12/11/2019] [Indexed: 12/17/2022]
|
11
|
Muliadi AR, Banda A, Mao C. Recent Progress in Roll Compaction Process Development for Pharmaceutical Solid Dosage Form Manufacture. CONTINUOUS PHARMACEUTICAL PROCESSING 2020. [DOI: 10.1007/978-3-030-41524-2_7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
|
12
|
Yu J, Xu B, Zhang K, Shi C, Zhang Z, Fu J, Qiao Y. Using a Material Library to Understand the Impacts of Raw Material Properties on Ribbon Quality in Roll Compaction. Pharmaceutics 2019; 11:pharmaceutics11120662. [PMID: 31817930 PMCID: PMC6956229 DOI: 10.3390/pharmaceutics11120662] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Revised: 11/09/2019] [Accepted: 12/04/2019] [Indexed: 12/19/2022] Open
Abstract
The purpose of this study is to use a material library to investigate the effect of raw material properties on ribbon tensile strength (TS) and solid fraction (SF) in the roll compaction (RC) process. A total of 81 pharmaceutical materials, including 53 excipients and 28 natural product powders (NPPs), were characterized by 22 material descriptors and were compacted under five different hydraulic pressures. The transversal and longitudinal splitting behaviors of the ribbons were summarized. The TS-porosity and TS-pressure relationships were used to explain the roll compaction behavior of powdered materials. Through defining the target ribbon quality (i.e., 0.6 ≤ SF ≤ 0.8 and TS ≥ 1 MPa), the roll compaction behavior classification system (RCBCS) was built and 81 materials were classified into three categories. A total of 24 excipients and five NPPs were classified as Category I materials, which fulfilled the target ribbon quality and had less occurrence of transversal splitting. Moreover, the multivariate relationships between raw material descriptors, the hydraulic pressure and ribbon quality attributes were obtained by PLS regression. Four density-related material descriptors and the cohesion index were identified as critical material attributes (CMAs). The multi-objective design space summarizing the feasible material properties and operational region for the RC process were visualized. The RCBCS presented in this paper enables a formulator to perform the initial risk assessment of any new materials, and the data modeling method helps to predict the impact of formulation ingredients on strength and porosity of compacts.
Collapse
Affiliation(s)
- Jiaqi Yu
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
| | - Bing Xu
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China; (Z.Z.); (J.F.)
- Correspondence: (B.X.); (Y.Q.); Tel.: +86-010-53912117 (B.X.)
| | - Kunfeng Zhang
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
| | - Chenfeng Shi
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
| | - Zhiqiang Zhang
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China; (Z.Z.); (J.F.)
- Beijing Tcmages Pharmceutical Co. LTD, Beijing 101301, China
| | - Jing Fu
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China; (Z.Z.); (J.F.)
- Beijing Tcmages Pharmceutical Co. LTD, Beijing 101301, China
| | - Yanjiang Qiao
- Department of Chinese Medicine Information Science, Beijing University of Chinese Medicine, Beijing 100029, China; (J.Y.); (K.Z.); (C.S.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China; (Z.Z.); (J.F.)
- Correspondence: (B.X.); (Y.Q.); Tel.: +86-010-53912117 (B.X.)
| |
Collapse
|
13
|
Chemometrics: a complementary tool to guide the isolation of pharmacologically active natural products. Drug Discov Today 2019; 25:27-37. [PMID: 31600581 DOI: 10.1016/j.drudis.2019.09.016] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2019] [Revised: 09/13/2019] [Accepted: 09/24/2019] [Indexed: 12/19/2022]
Abstract
Chemometrics offers an important complementary tool to enhance the searching and isolation of bioactive natural products from natural sources.
Collapse
|
14
|
Khan A. Optimization of the process variables of roller compaction, on the basis of granules characteristics (flow, mechanical strength, and disintegration behavior): an application of SeDeM-ODT expert system. Drug Dev Ind Pharm 2019; 45:1537-1546. [PMID: 31210544 DOI: 10.1080/03639045.2019.1634094] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
The objective of the study was application of SeDeM-ODT expert system for optimization of process variables for roller compaction and for the preparation of granules with better flow, compressibility, and disintegration behavior. In the present study, granules were prepared at pre-determined (on the basis of factorial design) process variables and characterized using SeDeM-ODT expert system. Compatibility of ribavirin with excipients (microcrystalline cellulose, tablettose-80, cross carmellose sodium, and magnesium stearate) was evaluated by binary mixture approach, using FTIR. According to the SeDeM-ODT expert system, granules were characterized for various parameters related to flow, compressibility and disintegration behavior and Index of Good Compressibility and Buccodispersibility (IGCB) was calculated. The process variables resulting in highest IGCB value were considered as optimum. Ribavirin was found compatible with all the excipients used in the study and characteristics peaks were present in FTIR spectra after subjecting to stress conditions (75% relative humidity at 45 ± 5 °C) for 30 days. Both Ribavirin powder and Ribavirin containing powder blend had poor flow and compressibility while disintegration behavior was good due to higher water solubility. Screw speed of 35 rpm and roller speed at 12 rpm resulted in granules with acceptable characteristics. The IGCB value (5.63) of the granules was highest of all, indicating its better characteristics. SeDeM-ODT expert system presents a more practical picture of the granules and also predicts the mechanical strength and disintegration behavior of the tablets prepared from the granules. By proper optimization of screw and roller speed, efficiency of the process can be improved.
Collapse
Affiliation(s)
- Amjad Khan
- a Department of Pharmacy , Kohat University of Science and Technology , Kohat , Pakistan
| |
Collapse
|
15
|
Paul S, Tajarobi P, Boissier C, Sun CC. Tableting performance of various mannitol and lactose grades assessed by compaction simulation and chemometrical analysis. Int J Pharm 2019; 566:24-31. [PMID: 31095984 DOI: 10.1016/j.ijpharm.2019.05.030] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2019] [Revised: 05/06/2019] [Accepted: 05/11/2019] [Indexed: 11/30/2022]
Abstract
Mannitol and lactose are commonly used fillers in pharmaceutical tablets, available in several commercial grades that are produced using different manufacturing processes. These grades significantly differ in particulate and powder properties that impact tablet manufacturability. Choice of sub-optimum type or grade of excipient in tablet formulation can lead to manufacturing problems and difficulties, which are magnified during a continuous manufacturing process. Previous characterization of tableting performance of these materials was limited in scope and under conditions not always realistic to the commercial production of tablets. This work seeks to comprehensively characterize the compaction properties of 11 mannitol and 5 lactose grades using a compaction simulator at both slow and fast tableting speeds. These include tabletability, compressibility, tablet brittleness, die-wall stress transmission, and strain rate sensitivity. A chemometrical analysis of data, using the partial least square technique, was performed to construct a model to provide accurate prediction of tablet tensile strength for mannitol grades. Such knowledge facilitates the selection of suitable tablet filler to attain high quality tablet products.
Collapse
Affiliation(s)
- Shubhajit Paul
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard Street S.E., Minneapolis, MN 55455, United States
| | - Pirjo Tajarobi
- Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden
| | - Catherine Boissier
- Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden
| | - Changquan Calvin Sun
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard Street S.E., Minneapolis, MN 55455, United States.
| |
Collapse
|
16
|
Haeffler G, Schmidt L, Lakio S, Reynolds G, Ödman J, Tajarobi P. A systematic study of the impact of changes of roller compactor equipment on granule and tablet properties. POWDER TECHNOL 2019. [DOI: 10.1016/j.powtec.2018.09.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
17
|
Pishnamazi M, Casilagan S, Clancy C, Shirazian S, Iqbal J, Egan D, Edlin C, Croker DM, Walker GM, Collins MN. Microcrystalline cellulose, lactose and lignin blends: Process mapping of dry granulation via roll compaction. POWDER TECHNOL 2019. [DOI: 10.1016/j.powtec.2018.07.003] [Citation(s) in RCA: 46] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Wiedey R, Kleinebudde P. Potentials and limitations of thermography as an in-line tool for determining ribbon solid fraction. POWDER TECHNOL 2019. [DOI: 10.1016/j.powtec.2018.03.047] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
19
|
|
20
|
Martinetz M, Karttunen AP, Sacher S, Wahl P, Ketolainen J, Khinast J, Korhonen O. RTD-based material tracking in a fully-continuous dry granulation tableting line. Int J Pharm 2018; 547:469-479. [DOI: 10.1016/j.ijpharm.2018.06.011] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2018] [Revised: 05/30/2018] [Accepted: 06/04/2018] [Indexed: 11/28/2022]
|
21
|
Twin Screw Granulation: Effects of Properties of Primary Powders. Pharmaceutics 2018; 10:pharmaceutics10020068. [PMID: 29865249 PMCID: PMC6027506 DOI: 10.3390/pharmaceutics10020068] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2018] [Revised: 05/28/2018] [Accepted: 05/30/2018] [Indexed: 11/17/2022] Open
Abstract
Lactose and mannitol are some of the most commonly used powders in the pharmaceutical industry. The limited research published so far highlights the effects of process and formulation parameters on the properties of the granules and the tablets produced using these two types of powders separately. However, the comparison of the performance of these two types of powders during twin screw wet granulation has received no attention. The present research is focused on understanding the granulation mechanism of different grades of two pharmaceutical powders with varying properties (i.e., primary particle size, structure, and compressibility). Three grades each of lactose and mannitol were granulated at varying liquid to solid ratios (L/S) and screw speed. It was noticed that primary powder morphology plays an important role in determining the granule size and structure, and tablet tensile strength. It was indicated that the processed powders such as spray-dried and granulated lactose and mannitol can be used in formulation for wet granulation where flowability of active pharmaceutical ingredient (API) is poor.
Collapse
|
22
|
Tarlier N, Soulairol I, Sanchez-Ballester N, Baylac G, Aubert A, Lefevre P, Bataille B, Sharkawi T. Deformation behavior of crystallized mannitol during compression using a rotary tablet press simulator. Int J Pharm 2018; 547:142-149. [PMID: 29777764 DOI: 10.1016/j.ijpharm.2018.05.026] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2018] [Revised: 05/02/2018] [Accepted: 05/10/2018] [Indexed: 10/16/2022]
Abstract
Mannitol is commonly used as a pharmaceutical excipient for tablets; the most widely used oral dosage form for drug delivery. For tableting, mannitol is provided in two different forms: native crystals and textured particles. In order to optimize its formulation, a good understanding of the mechanical behavior mechanism of mannitol is necessary. Thus, the aim of this study is to evaluate the deformation mechanism of native mannitol crystals presenting different particle sizes. Pharmaco-technical and compression studies were performed using mannitol with different mean diameters (160 µm, 50 µm and 25 µm). Lactose (monohydrate) and microcrystalline cellulose were used as brittle and plastic reference materials, respectively. Tableting tests and mathematical models, HECKEL and WALKER, were used to study the deformation mechanism of mannitol (β). Mean Yield Pressure (Py) and WALKER coefficient (W) values showed that the studied crystalline mannitol presents a deformation mechanism close to brittle material. A particle-size analyzer was used at different pulverization pressures to show the high sensibility of the mannitol particles to fragmentation when exposed to high pressures, especially for particles presenting 160 µm size. Scanning Electron Microscopy (SEM) was used to show the fragmentation after high-pressure measurements.
Collapse
Affiliation(s)
- Nicolas Tarlier
- Institut Charles Gerhardt UMR5253 Equipe MACS, UFR Science Pharmaceutique - Université Montpellier, Montpellier, France; Customer Technical Service Pharma, Roquette Freres, Lestrem, France.
| | - Ian Soulairol
- Institut Charles Gerhardt UMR5253 Equipe MACS, UFR Science Pharmaceutique - Université Montpellier, Montpellier, France; Department of Pharmacy, CHU Caremeau, Nimes, France
| | - Noelia Sanchez-Ballester
- Institut Charles Gerhardt UMR5253 Equipe MACS, UFR Science Pharmaceutique - Université Montpellier, Montpellier, France
| | - Gilles Baylac
- Institut Charles Gerhardt UMR5253 Equipe MACS, UFR Science Pharmaceutique - Université Montpellier, Montpellier, France
| | - Adrien Aubert
- Institut Charles Gerhardt UMR5253 Equipe MACS, UFR Science Pharmaceutique - Université Montpellier, Montpellier, France
| | - Philippe Lefevre
- Customer Technical Service Pharma, Roquette Freres, Lestrem, France
| | - Bernard Bataille
- Institut Charles Gerhardt UMR5253 Equipe MACS, UFR Science Pharmaceutique - Université Montpellier, Montpellier, France
| | - Tahmer Sharkawi
- Institut Charles Gerhardt UMR5253 Equipe MACS, UFR Science Pharmaceutique - Université Montpellier, Montpellier, France
| |
Collapse
|
23
|
Prediction of critical quality attributes and optimization of continuous dry granulation process via flowsheet modeling and experimental validation. POWDER TECHNOL 2018. [DOI: 10.1016/j.powtec.2018.02.042] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
24
|
Paul S, Chang SY, Dun J, Sun WJ, Wang K, Tajarobi P, Boissier C, Sun CC. Comparative analyses of flow and compaction properties of diverse mannitol and lactose grades. Int J Pharm 2018; 546:39-49. [PMID: 29705102 DOI: 10.1016/j.ijpharm.2018.04.058] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Revised: 04/24/2018] [Accepted: 04/25/2018] [Indexed: 11/25/2022]
Abstract
Appropriate selection of excipient grade during tablet formulation development depends on thorough knowledge in their compaction and flow properties. Each chemically unique pharmaceutical excipient is usually available in several commercial grades that are widely different in powder properties, which influence their performance for a specific formulation application. In this work, 11 grades of mannitol were systematically characterized, in terms of their particulate, flow and tableting properties, and compared against 5 grades of lactose. Principal component analysis (PCA) identified significant correlations among selected variables, such as particle size, surface area, flowability, wall friction, plasticity parameter, tensile strength, and tablet brittleness. PCA also revealed similar grades of the two excipients, which may be used to select replacement grade, if needed, based on similarity in their overall properties.
Collapse
Affiliation(s)
- Shubhajit Paul
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard Street S.E., Minneapolis, MN 55455, USA
| | - Shao-Yu Chang
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard Street S.E., Minneapolis, MN 55455, USA
| | - Jiangnan Dun
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard Street S.E., Minneapolis, MN 55455, USA
| | - Wei-Jhe Sun
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard Street S.E., Minneapolis, MN 55455, USA
| | - Kunlin Wang
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard Street S.E., Minneapolis, MN 55455, USA
| | | | | | - Changquan Calvin Sun
- Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard Street S.E., Minneapolis, MN 55455, USA.
| |
Collapse
|
25
|
Csordas K, Wiedey R, Kleinebudde P. Impact of roll compaction design, process parameters, and material deformation behaviour on ribbon relative density. Drug Dev Ind Pharm 2018; 44:1295-1306. [PMID: 29484952 DOI: 10.1080/03639045.2018.1446444] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Ribbons from microcrystalline cellulose (MCC), mannitol, and their 50:50% mixture were produced using the roll compactors AlexanderWerk BT120, Hosokawa Alpine Pharmapaktor C250, L.B. Bohle BRC 25, and Gerteis Mini-Pactor in the frame of multilevel full factorial experimental plans. The specific compaction force (SCF)/hydraulic pressure (HP), gap width (GW), roll speed, and fraction of MCC were analyzed as quantitative factors, whereas the roll surface and sealing system were examined as qualitative factors. Ribbon relative density was investigated as response of the models. The SCF/HP is found to be the most significant factor in each model. A significant inverse effect of the GW is obtained in the models of AlexanderWerk BT120, Pharmapaktor C250, and BRC 25 roll compactors, using smooth rolls. The principle of the establishment of a conversion factor (cf) is introduced based on the obtained data sets of AlexanderWerk BT120 and Mini-Pactor. This can facilitate the transfer of a roll compaction process between different types of roll compactors.
Collapse
Affiliation(s)
- Kitti Csordas
- a Institute of Pharmaceutics and Biopharmaceutics , Heinrich Heine University , Duesseldorf , Germany
| | - Raphael Wiedey
- a Institute of Pharmaceutics and Biopharmaceutics , Heinrich Heine University , Duesseldorf , Germany
| | - Peter Kleinebudde
- a Institute of Pharmaceutics and Biopharmaceutics , Heinrich Heine University , Duesseldorf , Germany
| |
Collapse
|
26
|
Stauffer F, Vanhoorne V, Pilcer G, Chavez PF, Rome S, Schubert MA, Aerts L, De Beer T. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing. Eur J Pharm Biopharm 2018; 127:92-103. [PMID: 29452241 DOI: 10.1016/j.ejpb.2018.02.017] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2017] [Revised: 02/12/2018] [Accepted: 02/12/2018] [Indexed: 10/18/2022]
Abstract
Active Pharmaceutical Ingredients (API) raw material variability is not always thoroughly considered during pharmaceutical process development, mainly due to low quantities of drug substance available. However, synthesis, crystallization routes and production sites evolve during product development and product life cycle leading to changes in physical material attributes which can potentially affect their processability. Recent literature highlights the need for a global approach to understand the link between material synthesis, material variability, process and product quality. The study described in this article aims at explaining the raw material variability of an API using extensive material characterization on a restricted number of representative batches using multivariate data analysis. It is part of a larger investigation trying to link the API drug substance manufacturing process, the resulting physical API raw material attributes and the drug product continuous manufacturing process. Eight API batches produced using different synthetic routes, crystallization, drying, delumping processes and processing equipment were characterized, extensively. Seventeen properties from seven characterization techniques were retained for further analysis using Principal Component Analysis (PCA). Three principal components (PCs) were sufficient to explain 92.9% of the API raw material variability. The first PC was related to crystal length, agglomerate size and fraction, flowability and electrostatic charging. The second PC was driven by the span of the particle size distribution and the agglomerates strength. The third PC was related to surface energy. Additionally, the PCA allowed to summarize the API batch-to-batch variability in only three PCs which can be used in future drug product development studies to quantitatively evaluate the impact of the API raw material variability upon the drug product process. The approach described in this article could be applied to any other compound which is prone to batch-to-batch variability.
Collapse
Affiliation(s)
- F Stauffer
- Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ghent, Belgium
| | - V Vanhoorne
- Laboratory of Pharmaceutical Technology, Ghent University, Ghent, Belgium
| | - G Pilcer
- Drug Delivery Design and Development, UCB, Braine l'Alleud, Belgium
| | - P-F Chavez
- Drug Delivery Design and Development, UCB, Braine l'Alleud, Belgium
| | - S Rome
- Analytical Sciences for Pharmaceuticals, UCB, Braine l'Alleud, Belgium
| | - M A Schubert
- Drug Delivery Design and Development, UCB, Braine l'Alleud, Belgium
| | - L Aerts
- Analytical Sciences for Pharmaceuticals, UCB, Braine l'Alleud, Belgium
| | - T De Beer
- Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ghent, Belgium.
| |
Collapse
|
27
|
Lakio S, Ervasti T, Tajarobi P, Wikström H, Fransson M, Karttunen AP, Ketolainen J, Folestad S, Abrahmsén-Alami S, Korhonen O. Provoking an end-to-end continuous direct compression line with raw materials prone to segregation. Eur J Pharm Sci 2017; 109:514-524. [DOI: 10.1016/j.ejps.2017.09.018] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2017] [Revised: 07/23/2017] [Accepted: 09/08/2017] [Indexed: 10/18/2022]
|
28
|
Zhang G, Zhao L, Zhu J, Feng Y, Wu X. Anti-inflammatory activities and glycerophospholipids metabolism in KLA-stimulated RAW 264.7 macrophage cells by diarylheptanoids from the rhizomes ofAlpinia officinarum. Biomed Chromatogr 2017; 32. [DOI: 10.1002/bmc.4094] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2016] [Revised: 08/31/2017] [Accepted: 09/07/2017] [Indexed: 12/14/2022]
Affiliation(s)
- Guogai Zhang
- Central Laboratory; Guangdong Pharmaceutical University; Guangzhou Guangdong China
| | - Lifang Zhao
- Qingdao Yellow Sea Pharmaceutical Co. Ltd; Qingdao Shandong China
| | - Jiancheng Zhu
- Central Laboratory; Guangdong Pharmaceutical University; Guangzhou Guangdong China
| | - Yifan Feng
- Central Laboratory; Guangdong Pharmaceutical University; Guangzhou Guangdong China
| | - Xia Wu
- Central Laboratory; Guangdong Pharmaceutical University; Guangzhou Guangdong China
| |
Collapse
|
29
|
On Identification of Critical Material Attributes for Compression Behaviour of Pharmaceutical Diluent Powders. MATERIALS 2017; 10:ma10070845. [PMID: 28773204 PMCID: PMC5551887 DOI: 10.3390/ma10070845] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/06/2017] [Revised: 06/14/2017] [Accepted: 07/20/2017] [Indexed: 11/16/2022]
Abstract
As one of the commonly-used solid dosage forms, pharmaceutical tablets have been widely used to deliver active drugs into the human body, satisfying patient's therapeutic requirements. To manufacture tablets of good quality, diluent powders are generally used in formulation development to increase the bulk of formulations and to bind other inactive ingredients with the active pharmaceutical ingredients (APIs). For formulations of a low API dose, the drug products generally consist of a large fraction of diluent powders. Hence, the attributes of diluents become extremely important and can significantly influence the final product property. Therefore, it is essential to accurately characterise the mechanical properties of the diluents and to thoroughly understand how their mechanical properties affect the manufacturing performance and properties of the final products, which will build a sound scientific basis for formulation design and product development. In this study, a comprehensive evaluation of the mechanical properties of the widely-used pharmaceutical diluent powders, including microcrystalline cellulose (MCC) powders with different grades (i.e., Avicel PH 101, Avicel PH 102, and DG), mannitol SD 100, lactose monohydrate, and dibasic calcium phosphate, were performed. The powder compressibility was assessed with Heckel and Kawakita analyses. The material elastic recovery during decompression and in storage was investigated through monitoring the change in the dimensions of the compressed tablets over time. The powder hygroscopicity was also evaluated to examine the water absorption ability of powders from the surroundings. It was shown that the MCC tablets exhibited continuous volume expansion after ejection, which is believed to be induced by (1) water absorption from the surrounding, and (2) elastic recovery. However, mannitol tablets showed volume expansion immediately after ejection, followed by the material shrinkage in storage. It is anticipated that the expansion was induced by elastic recovery to a limited extent, while the shrinkage was primarily due to the solidification during storage. It was also found that, for all powders considered, the powder compressibility and the elastic recovery depended significantly on the particle breakage tendency: a decrease in the particle breakage tendency led to a slight decrease in the powder compressibility and a significant drop in immediate elastic recovery. This implies that the particle breakage tendency is a critical material attribute in controlling the compression behaviour of pharmaceutical powders.
Collapse
|
30
|
Sun F, Xu B, Zhang Y, Dai S, Yang C, Cui X, Shi X, Qiao Y. Statistical modeling methods to analyze the impacts of multiunit process variability on critical quality attributes of Chinese herbal medicine tablets. DRUG DESIGN DEVELOPMENT AND THERAPY 2016; 10:3909-3924. [PMID: 27932865 PMCID: PMC5135065 DOI: 10.2147/dddt.s119122] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The quality of Chinese herbal medicine tablets suffers from batch-to-batch variability due to a lack of manufacturing process understanding. In this paper, the Panax notoginseng saponins (PNS) immediate release tablet was taken as the research subject. By defining the dissolution of five active pharmaceutical ingredients and the tablet tensile strength as critical quality attributes (CQAs), influences of both the manipulated process parameters introduced by an orthogonal experiment design and the intermediate granules’ properties on the CQAs were fully investigated by different chemometric methods, such as the partial least squares, the orthogonal projection to latent structures, and the multiblock partial least squares (MBPLS). By analyzing the loadings plots and variable importance in the projection indexes, the granule particle sizes and the minimal punch tip separation distance in tableting were identified as critical process parameters. Additionally, the MBPLS model suggested that the lubrication time in the final blending was also important in predicting tablet quality attributes. From the calculated block importance in the projection indexes, the tableting unit was confirmed to be the critical process unit of the manufacturing line. The results demonstrated that the combinatorial use of different multivariate modeling methods could help in understanding the complex process relationships as a whole. The output of this study can then be used to define a control strategy to improve the quality of the PNS immediate release tablet.
Collapse
Affiliation(s)
- Fei Sun
- Research Center of Traditional Chinese Medicine Information Engineering, School of Chinese Materia Medica, Beijing University of Chinese Medicine
| | - Bing Xu
- Research Center of Traditional Chinese Medicine Information Engineering, School of Chinese Materia Medica, Beijing University of Chinese Medicine; Key Laboratory of Manufacture Process Control and Quality Evaluation of Chinese Medicine, Beijing, People's Republic of China
| | - Yi Zhang
- Research Center of Traditional Chinese Medicine Information Engineering, School of Chinese Materia Medica, Beijing University of Chinese Medicine
| | - Shengyun Dai
- Research Center of Traditional Chinese Medicine Information Engineering, School of Chinese Materia Medica, Beijing University of Chinese Medicine
| | - Chan Yang
- Research Center of Traditional Chinese Medicine Information Engineering, School of Chinese Materia Medica, Beijing University of Chinese Medicine
| | - Xianglong Cui
- Research Center of Traditional Chinese Medicine Information Engineering, School of Chinese Materia Medica, Beijing University of Chinese Medicine
| | - Xinyuan Shi
- Research Center of Traditional Chinese Medicine Information Engineering, School of Chinese Materia Medica, Beijing University of Chinese Medicine; Key Laboratory of Manufacture Process Control and Quality Evaluation of Chinese Medicine, Beijing, People's Republic of China
| | - Yanjiang Qiao
- Research Center of Traditional Chinese Medicine Information Engineering, School of Chinese Materia Medica, Beijing University of Chinese Medicine; Key Laboratory of Manufacture Process Control and Quality Evaluation of Chinese Medicine, Beijing, People's Republic of China
| |
Collapse
|
31
|
Panzitta M, Ponti M, Bruno G, Cois G, D'Arpino A, Minghetti P, Mendicino FR, Perioli L, Ricci M. The strategic relevance of manufacturing technology: An overall quality concept to promote innovation preventing drug shortage. Int J Pharm 2016; 516:144-157. [PMID: 27838294 DOI: 10.1016/j.ijpharm.2016.11.018] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2016] [Revised: 11/01/2016] [Accepted: 11/04/2016] [Indexed: 11/25/2022]
Abstract
Manufacturing is the bridge between research and patient: without product, there is no clinical outcome. Shortage has a variety of causes, in this paper we analyse only causes related to manufacturing technology and we use shortage as a paradigm highliting the relevance of Pharmaceutical Technology. Product and process complexity and capacity issues are the main challenge for the Pharmaceutical Industry Supply chain. Manufacturing Technology should be acknowledged as a R&D step and as a very important matter during University degree in Pharmacy and related disciplines, promoting collaboration between Academia and Industry, measured during HTA step and rewarded in terms of price and reimbursement. The above elements are not yet properly recognised, and manufacturing technology is taken in to consideration only when a shortage is in place. In a previous work, Panzitta et al. proposed to perform a full technology assessment at the Health Technological Assessment stage, evaluating three main technical aspects of a medicine: manufacturing process, physicochemical properties, and formulation characteristics. In this paper, we develop the concept of manufacturing appraisal, providing a technical overview of upcoming challenges, a risk based approach and an economic picture of shortage costs. We develop also an overall quality concept, not limited to GMP factors but broaden to all elements leading to a robust supply and promoting technical innovation.
Collapse
Affiliation(s)
- Michele Panzitta
- Department of Pharmaceutical Sciences Università degli Studi di Perugia, Via del Liceo 1, 06123 Perugia, Italy; AFI, Study Group on Pharmaceutical Economy, Viale Ranzoni 1 20041 Milano, Italy
| | - Mauro Ponti
- AFI, Study Group on Pharmaceutical Economy, Viale Ranzoni 1 20041 Milano, Italy; Sanofi-Genzyme, Viale Luigi Bodio 37/b, 20158 Milano, Italy
| | - Giorgio Bruno
- AFI-Associazione Farmaceutici dell'Industria, viale Ranzoni 1, 20041 Milano, Italy; Recipharm AB, Via Filippo Serpero, 2, Masate (MI), Italy
| | - Giancarlo Cois
- AFI, Study Group on Pharmaceutical Economy, Viale Ranzoni 1 20041 Milano, Italy; Chiesi Via San Leonardo, 96A, 43122 Parma, Italy
| | - Alessandro D'Arpino
- AFI, Study Group on Pharmaceutical Economy, Viale Ranzoni 1 20041 Milano, Italy; Perugia Hospital, Pharmacy Department, 06132 Sant'Andrea delle Fratte, Perugia, Italy
| | - Paola Minghetti
- AFI-Associazione Farmaceutici dell'Industria, viale Ranzoni 1, 20041 Milano, Italy; School of Hospital Pharmacy, Pharmaceutical Sciences Department, Università degli Studi di Milano, Via Festa del Perdono 7 - Milano, Italy
| | | | - Luana Perioli
- Department of Pharmaceutical Sciences Università degli Studi di Perugia, Via del Liceo 1, 06123 Perugia, Italy
| | - Maurizio Ricci
- Department of Pharmaceutical Sciences Università degli Studi di Perugia, Via del Liceo 1, 06123 Perugia, Italy; AFI, Study Group on Pharmaceutical Economy, Viale Ranzoni 1 20041 Milano, Italy; School of Hospital Pharmacy, Università degli Studi di Perugia, Via del Liceo 1, 06123 Perugia, Italy.
| |
Collapse
|
32
|
Pérez Gago A, Kleinebudde P. MCC-mannitol mixtures after roll compaction/dry granulation: percolation thresholds for ribbon microhardness and granule size distribution. Pharm Dev Technol 2016; 22:764-774. [PMID: 27055487 DOI: 10.3109/10837450.2016.1163388] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
In roll compaction, the specific compaction force, the gap width and the roll speed are the most important settings as they have a high impact in the products obtained. However the mechanical properties of the mixture being compacted are also critical. For this reason, a multilevel full factorial design including these parameters as factors plus three repetitions of the center point was performed for microcrystalline cellulose, mannitol and five binary mixtures (15, 30, 50, 70 and 85% MCC). These two reference excipients were chosen in order to investigate the plastic/brittle behavior of mixtures for the roll compaction process. These materials were roll compacted in a 3-W-Polygran® 250/50/3 (Gerteis) and the ribbons obtained were collected and milled into granules which were characterized regarding granule size distribution. After statistical evaluation, it was found that the most critical factors affecting the D10, D50, D90 and the fines fraction from the granules were the gap width and the specific compaction force, as well as the proportion of MCC together with its quadratic effect and the interaction between force and proportion of MCC. The microhardness of the ribbons from the center point as well as the D10, D50, D90 and the fines fraction from the granules produced at these same conditions were characterized. In all the cases, the proportion of MCC, i.e. the composition of the mixture, showed also an important effect on these properties measured. In this sense, the percolation theory was applied in order to study further the importance of the plastic/brittle ratio by calculating the percolation threshold or the limit over which the behavior of the system changes. This resulted in values of 34% for the HU (expression of microhardness), 27% and 28% for the D10 and fines, respectively (percolation of MCC) and 84% and 85% for the D50 and D90, respectively (percolation of mannitol).
Collapse
Affiliation(s)
- Ana Pérez Gago
- a Institute of Pharmaceutics and Biopharmaceutics , Heinrich-Heine-University , Düsseldorf , Germany
| | - Peter Kleinebudde
- a Institute of Pharmaceutics and Biopharmaceutics , Heinrich-Heine-University , Düsseldorf , Germany
| |
Collapse
|
33
|
|
34
|
Omar CS, Dhenge RM, Osborne JD, Althaus TO, Palzer S, Hounslow MJ, Salman AD. Roller compaction: Effect of morphology and amorphous content of lactose powder on product quality. Int J Pharm 2015; 496:63-74. [DOI: 10.1016/j.ijpharm.2015.06.032] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2015] [Revised: 05/28/2015] [Accepted: 06/19/2015] [Indexed: 10/23/2022]
|
35
|
Rantanen J, Khinast J. The Future of Pharmaceutical Manufacturing Sciences. J Pharm Sci 2015; 104:3612-3638. [PMID: 26280993 PMCID: PMC4973848 DOI: 10.1002/jps.24594] [Citation(s) in RCA: 198] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2014] [Revised: 06/26/2015] [Accepted: 06/29/2015] [Indexed: 12/13/2022]
Abstract
The entire pharmaceutical sector is in an urgent need of both innovative technological solutions and fundamental scientific work, enabling the production of highly engineered drug products. Commercial-scale manufacturing of complex drug delivery systems (DDSs) using the existing technologies is challenging. This review covers important elements of manufacturing sciences, beginning with risk management strategies and design of experiments (DoE) techniques. Experimental techniques should, where possible, be supported by computational approaches. With that regard, state-of-art mechanistic process modeling techniques are described in detail. Implementation of materials science tools paves the way to molecular-based processing of future DDSs. A snapshot of some of the existing tools is presented. Additionally, general engineering principles are discussed covering process measurement and process control solutions. Last part of the review addresses future manufacturing solutions, covering continuous processing and, specifically, hot-melt processing and printing-based technologies. Finally, challenges related to implementing these technologies as a part of future health care systems are discussed.
Collapse
Affiliation(s)
- Jukka Rantanen
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
| | - Johannes Khinast
- Institute of Process and Particle Engineering, Graz University of Technology, Graz, Austria; Research Center Pharmaceutical Engineering, Graz, Austria.
| |
Collapse
|
36
|
Compaction behavior and deformation mechanism of directly compressible textured mannitol in a rotary tablet press simulator. Int J Pharm 2015; 495:410-419. [PMID: 26363108 DOI: 10.1016/j.ijpharm.2015.09.007] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2015] [Revised: 09/02/2015] [Accepted: 09/08/2015] [Indexed: 11/21/2022]
Abstract
Textured mannitol powder is widely used as a pharmaceutical excipient for tablet compaction. In order to choose the right tableting parameters, it is necessary to understand its mechanical behavior during deformation under industrial tableting conditions. The aim of this study was to evaluate the mechanical behavior during deformation of a textured mannitol using a rotary tablet press simulator. Mean yield pressure (Py) obtained by Heckel modeling, Walker coefficients (W) and Stress Rate Sensitivity (SRS) were compared to reference excipients, known for either their plastic (microcrystalline cellulose) or fragmentary (lactose and dibasic calcium phosphate) deformation behavior. Py, W and SRS values showed that the studied textured mannitol has a fragmentary deformation mechanism. Furthermore, this mechanical behavior was not sensitive to lubrication, which is characteristic of fragmentary excipients.
Collapse
|
37
|
Boersen N, Carvajal MT, Morris KR, Peck GE, Pinal R. The influence of API concentration on the roller compaction process: modeling and prediction of the post compacted ribbon, granule and tablet properties using multivariate data analysis. Drug Dev Ind Pharm 2015; 41:1470-8. [PMID: 25212638 DOI: 10.3109/03639045.2014.958754] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
OBJECTIVE While previous research has demonstrated roller compaction operating parameters strongly influence the properties of the final product, a greater emphasis might be placed on the raw material attributes of the formulation. There were two main objectives to this study. First, to assess the effects of different process variables on the properties of the obtained ribbons and downstream granules produced from the rolled compacted ribbons. Second, was to establish if models obtained with formulations of one active pharmaceutical ingredient (API) could predict the properties of similar formulations in terms of the excipients used, but with a different API. MATERIALS AND METHODS Tolmetin and acetaminophen, chosen for their different compaction properties, were roller compacted on Fitzpatrick roller compactor using the same formulation. Models created using tolmetin and tested using acetaminophen. The physical properties of the blends, ribbon, granule and tablet were characterized. Multivariate analysis using partial least squares was used to analyze all data. RESULTS Multivariate models showed that the operating parameters and raw material attributes were essential in the prediction of ribbon porosity and post-milled particle size. The post compacted ribbon and granule attributes also significantly contributed to the prediction of the tablet tensile strength. CONCLUSIONS Models derived using tolmetin could reasonably predict the ribbon porosity of a second API. After further processing, the post-milled ribbon and granules properties, rather than the physical attributes of the formulation were needed to predict downstream tablet properties. An understanding of the percolation threshold of the formulation significantly improved the predictive ability of the models.
Collapse
|
38
|
Understanding the impact of microcrystalline cellulose physicochemical properties on tabletability. Int J Pharm 2015; 490:47-54. [DOI: 10.1016/j.ijpharm.2015.05.026] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2015] [Revised: 05/07/2015] [Accepted: 05/09/2015] [Indexed: 11/22/2022]
|
39
|
Souihi N, Reynolds G, Tajarobi P, Wikström H, Haeffler G, Josefson M, Trygg J. Roll compaction process modeling: Transfer between equipment and impact of process parameters. Int J Pharm 2015; 484:192-206. [DOI: 10.1016/j.ijpharm.2015.02.042] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2014] [Revised: 02/13/2015] [Accepted: 02/16/2015] [Indexed: 11/17/2022]
|
40
|
Souihi N, Nilsson D, Josefson M, Trygg J. Near-infrared chemical imaging (NIR-CI) on roll compacted ribbons and tablets – multivariate mapping of physical and chemical properties. Int J Pharm 2015; 483:200-11. [DOI: 10.1016/j.ijpharm.2015.02.006] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2014] [Accepted: 02/01/2015] [Indexed: 11/25/2022]
|
41
|
Heiman J, Tajarobi F, Gururajan B, Juppo A, Abrahmsén-Alami S. Roller compaction of hydrophilic extended release tablets-combined effects of processing variables and drug/matrix former particle size. AAPS PharmSciTech 2015; 16:267-77. [PMID: 25273028 DOI: 10.1208/s12249-014-0219-3] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2014] [Accepted: 09/10/2014] [Indexed: 11/30/2022] Open
Abstract
The present study shows that roller compaction (RC) can successfully be used as a granulation method to prepare hydroxypropyl methylcellulose (HPMC)-based extended release matrix tablets containing a high drug load, both for materials deforming mainly by fragmentation (paracetamol) as for those having mainly plastic deformation (ibuprofen). The combined effect of RC process variables and composition on the manufacturability of HPMC tablets was investigated. Standard wet granulation grade HPMC was compared with a larger particle size direct compressible HPMC grade. Higher roll pressure was found to result in larger paracetamol granules and narrower granule particle size distributions, especially for formulations containing smaller size HPMC. However, for ibuprofen, no clear effect of roll pressure was observed. High roll pressure also resulted in denser ribbon and less bypass fines during RC. Loss of compactibility was observed for granules compared to powder blends, which was found to be related to differences in granule porosity and morphology. Using the large-sized HPMC grade did in some cases result in lower tensile strength tablets but had the advantage to improve the powder flow into the roller compactor. This work also indicates that when the HPMC level lies near the percolation threshold, significant changes can occur in the drug release rate due to changes in other factors (raw material characteristics and processing).
Collapse
|
42
|
Myerson AS, Krumme M, Nasr M, Thomas H, Braatz RD. Control Systems Engineering in Continuous Pharmaceutical Manufacturing May 20–21, 2014 Continuous Manufacturing Symposium. J Pharm Sci 2015; 104:832-839. [DOI: 10.1002/jps.24311] [Citation(s) in RCA: 75] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2014] [Revised: 10/22/2014] [Accepted: 10/23/2014] [Indexed: 01/18/2023]
|
43
|
Kamran F, Abildgaard OHA, Sparén A, Svensson O, Johansson J, Andersson-Engels S, Andersen PE, Khoptyar D. Transmission near-infrared (NIR) and photon time-of-flight (PTOF) spectroscopy in a comparative analysis of pharmaceuticals. APPLIED SPECTROSCOPY 2015; 69:389-397. [PMID: 25664562 DOI: 10.1366/14-07530] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
We present a comprehensive study of the application of photon time-of-flight spectroscopy (PTOFS) in the wavelength range 1050-1350 nm as a spectroscopic technique for the evaluation of the chemical composition and structural properties of pharmaceutical tablets. PTOFS is compared to transmission near-infrared spectroscopy (NIRS). In contrast to transmission NIRS, PTOFS is capable of directly and independently determining the absorption and reduced scattering coefficients of the medium. Chemometric models were built on the evaluated absorption spectra for predicting tablet drug concentration. Results are compared to corresponding predictions built on transmission NIRS measurements. The predictive ability of PTOFS and transmission NIRS is comparable when models are based on uniformly distributed tablet sets. For non-uniform distribution of tablets based on particle sizes, the prediction ability of PTOFS is better than that of transmission NIRS. Analysis of reduced scattering spectra shows that PTOFS is able to characterize tablet microstructure and manufacturing process parameters. In contrast to the chemometric pseudo-variables provided by transmission NIRS, PTOFS provides physically meaningful quantities such as scattering strength and slope of particle size. The ability of PTOFS to quantify the reduced scattering spectra, together with its robustness in predicting drug content, makes it suitable for such evaluations in the pharmaceutical industry.
Collapse
Affiliation(s)
- Faisal Kamran
- Department of Photonics Engineering, Technical University of Denmark, Frederiksborg 399, 4000 Denmark
| | | | | | | | | | | | | | | |
Collapse
|
44
|
OPLS in batch monitoring - Opens up new opportunities. Anal Chim Acta 2014; 857:28-38. [PMID: 25604817 DOI: 10.1016/j.aca.2014.12.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2014] [Revised: 11/26/2014] [Accepted: 12/02/2014] [Indexed: 12/28/2022]
Abstract
In batch statistical process control (BSPC), data from a number of "good" batches are used to model the evolution (trajectory) of the process and they also define model control limits, against which new batches may be compared. The benchmark methods used in BSPC include partial least squares (PLS) and principal component analysis (PCA). In this paper, we have used orthogonal projections to latent structures (OPLS) in BSPC and compared the results with PLS and PCA. The experimental study used was a batch hydrogenation reaction of nitrobenzene to aniline characterized by both UV spectroscopy and process data. The key idea is that OPLS is able to separate the variation in data that is correlated to the process evolution (also known as 'batch maturity index') from the variation that is uncorrelated to process evolution. This separation of different types of variations can generate different batch trajectories and hence lead to different established model control limits to detect process deviations. The results demonstrate that OPLS was able to detect all process deviations and provided a good process understanding of the root causes for these deviations. PCA and PLS on the other hand were shown to provide different interpretations for several of these process deviations, or in some cases they were unable to detect actual process deviations. Hence, the use of OPLS in BSPC can lead to better fault detection and root cause analysis as compared to existing benchmark methods and may therefore be used to complement the existing toolbox.
Collapse
|
45
|
Fonteyne M, Wickström H, Peeters E, Vercruysse J, Ehlers H, Peters BH, Remon JP, Vervaet C, Ketolainen J, Sandler N, Rantanen J, Naelapää K, De Beer T. Influence of raw material properties upon critical quality attributes of continuously produced granules and tablets. Eur J Pharm Biopharm 2014; 87:252-63. [PMID: 24589422 DOI: 10.1016/j.ejpb.2014.02.011] [Citation(s) in RCA: 61] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2013] [Revised: 02/20/2014] [Accepted: 02/21/2014] [Indexed: 11/28/2022]
Abstract
Continuous manufacturing gains more and more interest within the pharmaceutical industry. The International Conference of Harmonisation (ICH) states in its Q8 'Pharmaceutical Development' guideline that the manufacturer of pharmaceuticals should have an enhanced knowledge of the product performance over a range of raw material attributes, manufacturing process options and process parameters. This fits further into the Process Analytical Technology (PAT) and Quality by Design (QbD) framework. The present study evaluates the effect of variation in critical raw material properties on the critical quality attributes of granules and tablets, produced by a continuous from-powder-to-tablet wet granulation line. The granulation process parameters were kept constant to examine the differences in the end product quality caused by the variability of the raw materials properties only. Theophylline-Lactose-PVP (30-67.5-2.5%) was used as model formulation. Seven different grades of theophylline were granulated. Afterward, the obtained granules were tableted. Both the characteristics of granules and tablets were determined. The results show that differences in raw material properties both affect their processability and several critical quality attributes of the resulting granules and tablets.
Collapse
Affiliation(s)
- Margot Fonteyne
- Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ghent, Belgium.
| | - Henrika Wickström
- Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ghent, Belgium; Pharmaceutical Sciences Laboratory, Department of Biosciences, Åbo Akademi University, Turku, Finland
| | - Elisabeth Peeters
- Laboratory of Pharmaceutical Technology, Ghent University, Ghent, Belgium
| | - Jurgen Vercruysse
- Laboratory of Pharmaceutical Technology, Ghent University, Ghent, Belgium
| | - Henrik Ehlers
- Pharmaceutical Sciences Laboratory, Department of Biosciences, Åbo Akademi University, Turku, Finland
| | | | - Jean Paul Remon
- Laboratory of Pharmaceutical Technology, Ghent University, Ghent, Belgium
| | - Chris Vervaet
- Laboratory of Pharmaceutical Technology, Ghent University, Ghent, Belgium
| | | | - Niklas Sandler
- Pharmaceutical Sciences Laboratory, Department of Biosciences, Åbo Akademi University, Turku, Finland
| | - Jukka Rantanen
- Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark
| | - Kaisa Naelapää
- Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark
| | - Thomas De Beer
- Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ghent, Belgium.
| |
Collapse
|
46
|
Latent variable modeling to assist the implementation of Quality-by-Design paradigms in pharmaceutical development and manufacturing: A review. Int J Pharm 2013; 457:283-97. [DOI: 10.1016/j.ijpharm.2013.08.074] [Citation(s) in RCA: 70] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2013] [Revised: 08/27/2013] [Accepted: 08/28/2013] [Indexed: 11/19/2022]
|
47
|
Wagner CM, Pein M, Breitkreutz J. Roll compaction of mannitol: Compactability study of crystalline and spray-dried grades. Int J Pharm 2013; 453:416-22. [DOI: 10.1016/j.ijpharm.2013.05.024] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2013] [Revised: 05/07/2013] [Accepted: 05/11/2013] [Indexed: 10/26/2022]
|
48
|
Souihi N, Josefson M, Tajarobi P, Gururajan B, Trygg J. Design Space Estimation of the Roller Compaction Process. Ind Eng Chem Res 2013. [DOI: 10.1021/ie303580y] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Nabil Souihi
- Computational Life Science Cluster
(CLiC), Department of Chemistry, Umeå University, SE-90187 Umeå,
Sweden
| | - Mats Josefson
- Pharmaceutical Development, AstraZeneca R&D Mölndal, SE-431 83, Sweden
| | - Pirjo Tajarobi
- Pharmaceutical Development, AstraZeneca R&D Mölndal, SE-431 83, Sweden
| | - Bindhu Gururajan
- Pharmaceutical Development, AstraZeneca R&D Mölndal, SE-431 83, Sweden
| | - Johan Trygg
- Computational Life Science Cluster
(CLiC), Department of Chemistry, Umeå University, SE-90187 Umeå,
Sweden
| |
Collapse
|